Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.7B | 9.2B | 8.3B | 8.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 3.1B | 3.4B | 2.9B | 2.9B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.6B | 2.8B | 3.0B | 2.4B |
| Tax provision | 644M | 690M | 703M | 582M |
| Net income | 2.0B | 2.1B | 2.3B | 1.9B |
| Basic EPS | 2.5 | 2.8 | — | 2.5 |
| Diluted EPS | 2.5 | 2.8 | — | 2.5 |
| Basic average shares | 725.4M | 729.6M | — | 729.4M |
| Diluted average shares | 726.4M | 730.7M | — | 730.2M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 2.0B | 2.1B | 2.3B | 1.9B |
| Minority interests | -2M | -4M | -3M | 0 |
| Preferred stock dividends | — | — | — | — |